• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,563.92 -1,470.50
( -1.93%)
Global Indices
Nasdaq
46,583.62 -115.24
(-0.25%)
Dow Jones
6,653.27 -40.35
(-0.60%)
Hang Seng
53,838.16 -614.80
(-1.13%)
Nikkei 225
10,249.42 -55.73
(-0.54%)
Forex
USD-INR
92.29 0.37
(0.40%)
EUR-INR
106.44 -0.15
(-0.14%)
GBP-INR
123.36 -0.03
(-0.03%)
JPY-INR
0.58 0.00
(0.05%)

EQUITY - MARKET SCREENER

Panchsheel Organics Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
531726
INE316G01019
104.9661966
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PANCHSHEEL
11.04
135.8
EPS(TTM)
Face Value()
Div & Yield %
9.34
10
0.78
 

IIFL Finance to consider NCD issuance on 24 February
Feb 20,2026
In an earlier exchange filing dated 8 May 2025, the company had stated that it plans to raise funds through the issuance of NCDs on a private placement basis, with an aggregate limit of up to Rs 10,000 crore.

IIFL Finance is one of India's leading retail-focused diversified NBFCs, engaged in the business of loans and mortgages through its subsidiaries, IIFL Home Finance and IIFL Samasta Finance. The company offers a wide spectrum of products, including home loans, gold loans, business loans, microfinance, capital market finance, and developer & construction finance, serving over 8 million customers through a pan-India network of 4,900+ branches and digital channels.

The company’s consolidated net profit surged 513.6% to Rs 501.35 crore in Q3 FY26, compared with Rs 81.71 crore in Q3 FY25. Total income jumped 40.2% YoY to Rs 3,432.79 crore in Q3 FY26.

Shares of IIFL Finance slipped 1.68% to settle at Rs 488.75 on the BSE.